Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and approve 1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2025. 2. recommend payment of Final Dividend, if any, for the Financial Year ended March 31, 2025.